Early DiAgnosis Real-Time Healthcare System for CANcer Trial
The purpose of the study is to assess whether the AI characterisation system of the CADDIE device improves the endoscopists accuracy in the optical diagnosis of diminutive colorectal polyps in the bowel during colonoscopy. Participants will either have a colonoscopy with the assistance of the CADDIE device characterisation AI system (intervention group) or have a colonoscopy in line with routine clinical practice i.e., without the CADDIE device characterisation AI system (control group). The randomisation method of this trial will allocate enrolled participants to the intervention group and to the control group by a technique similar to flipping a coin.
• Participants scheduled to undergo a screening, surveillance or symptomatic colonoscopy with an endoscopist participating in the study phase of the trial.
• Male and female participants aged 18 years or older at the time of informed consent.
• Participants able to comprehend, sign and date the written informed consent document to participate in the study.